Traveller's diarrhea: Epidemiology, clinical practice guideline for the prevention and treatment;Diarrhées du voyageur : Épidémiologie, prévention et conduite à tenir

Presse Medicale

Volumn 42, Issue 1, 2013, Pages 76-81

  Marchou, Bruno ^a  

^a CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL CRAMP; ARCOBACTER; BACTEREMIA; BACTEROIDES FRAGILIS; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; DEHYDRATION; ENTEROADHERENT ESCHERICHIA COLI; ENTEROCOLITIS; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; FECES ANALYSIS; FOOD HANDLING; HAND WASHING; HUMAN; IMMUNOCOMPROMISED PATIENT; NONHUMAN; ORAL REHYDRATION THERAPY; SALMONELLA; SALMONELLOSIS; SHIGELLA; SHIGELLOSIS; SHORT SURVEY; TENESMUS; TRAVELLER DIARRHEA; TREATMENT DURATION; VERNER MORRISON SYNDROME;

ACUTE DISEASE; CHRONIC DISEASE; DIARRHEA; FOOD MICROBIOLOGY; HAND HYGIENE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; TRAVEL;

EID: 84872014971     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.10.008     Document Type: Short Survey

References (27)

1. Casburn-Jones A.C., Farthing M.J.G. Traveler's diarrhea. J Gastroenterol Hepatol 2004, 19:610-618.
2. DuPont H.L. New insights and directions in traveler's diarrhea. Gastroenterol Clin North Am 2006, 35:337-353.
3. Steffen R., Tornieporth N., Clemens S.A., Chatterjee S., Cavalcanti A.M., Collard F., et al. Epidemiology of traveler's diarrhea: details of a global study. J Travel Med 2004, 11:231-238.
4. Cheng A.C., Thielman N.M. Update on traveler's diarrhea. Curr Infect Dis Rep 2002, 4:70-77.
5. Jiang Z.D., Dupont H.L., Brown E.L., Nandy R.K., Ramamurthy T., Sinha A., et al. Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species. J Clin Microbiol 2010, 48:1417-1419.
6. World Tourism Organization. Tourism highlights 2009 ed. United Nations World Tourism Organization, Geneva, Switzerland.
7. Baaten G.G., Geskus R.B., Kint J.A., Roukens A.H.E., Sonder G.J., Van de Hoek A. Symptoms of infectious diseases in immunocompromised travelers: a prospective study with matched controls. J Travel Med 2011, 18:318-326.
8. De la Cabada Bauche J., DuPont H.L. New developments in traveler's diarrhea. Gastroenterol Hepatol 2011, 7(2):88-95.
9. Shah N., DuPont H.L., Ramsey D.J. Global etiology of travelers' diarrhea: systematic review from 1973 to the present. Am J Trop Med 2009, 80:609-614.
10. Von Sonnenburg F., Tornieporth N., Waiyaki P., Lowe B., Peruski L.F., DuPont H.L., et al. Risk and etiology of diarrhoea at various tourist destinations. Lancet 2000, 356:133-134.
11. Meraz I.M., Jiang Z.D., Ericsson C.D., Bourgeois A.L., Steffen R., Taylor D.N., et al. ETEC EADC as likely causes of a proportion of pathogen negative traveler's diarrhea. A PCR-based study. J Travel Med 2008, 15:412-418.
12. Steffen R. Epidemiology of traveler's diarrhea. Clin Infect Dis 2005, 41(Suppl. 8):S536-S540.
13. Soonawala D., Vlot J.A., Visser L.G. Inconvenience due to traveler's diarrhea: a prospective follow-up study. BMC Infect Dis 2011, 11:322.
14. DuPont A.W. Post-infectious irritable bowel syndrome. Clin Infect Dis 2008, 46:594-599.
15. Pitzurra R., Fried M., Rogler G., Rammert C., Tschopp A., Hatz C., et al. Irritable bowel syndrome among a cohort of european travelers to resource-limited destinations. J Travel Med 2011, 18:250-256.
16. De Saussure P.P.H. Management of the returning traveler with diarrhea. Ther Adv Gastroenterol 2009, 2(6):367-375.
17. Kean B.H. The diarrhea of travelers to Mexico. Summary of five-year study. Ann Intern Med 1963, 59:605-614.
18. Sack D.A., Kaminsky D.C., Sack R.B., Itotia J.N., Arthur R.R., Kapikian A.Z., et al. Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med 1978, 298:758-763.
19. Rademaker C.M., Hoepelman I.M., Wolfhagen M.J., Beumer H., Rozenberg-Arska M., Verhoef J. Results of a double blind placebo-controlled study using ciprofloxacin for prevention of traveler's diarrhea. Eur J Clin Microbiol Infect Dis 1989, 8:690-694.
20. Gorbach S., Edelman R. Traveler's diarrhea: National Institutes of Health Consensus Development Conference. Rev Infect Dis 1986, 8:S109-S233.
21. Ouyang-Latimer J., Jafri S., VanTassel A., Jiang Z.D., Gurleen K., Rodriguez S., et al. In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala and India from 2006-2008. Antimicrob Agents Chemother 2011, 55(2):874-878.
22. DuPont H.L., Jiang Z.D., Okhuysen P.C., Ericsson C.D., de la Cabada F.J., Ke S., et al. A randomized double-blind, placebo-controlled trial of rifaximin to prevent traveler's diarrhea. Ann Intern Med 2005, 142:805-812.
23. DuPont H.L., Ericsson C.D., Farthing M.J., Gorbach S., Pickering L.K., Rombo L., et al. Expert Review of the evidence base for prevention of travelers diarrhea. J Travel Med 2009, 16(3):149-160.
24. Briand V., Buffet P., Genty S., Lacombe K., Godineau N., Salomon J., et al. Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin Infect Dis 2006, 43:1170-1175.
25. Lundkvist J., Steffen R., Jönsson B. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers's diarrhea. J Travel Med 2009, 16:28-34.
26. De Bruyn G., Hahn S., Borwick A. Antibiotic treatment for traveler's diarrhea. Cochrane Database Syst Rev 2000, CD 002242.
27. Hill D.R., Ericsson C.D., Pearson R.D., Keystone J.S., Freedman D.O., Kozarsky P.E., et al. The practice of travel medicine: guidelines by the IDSA. Clin Infect Dis 2006, 43:1499-1539.